|
17
|
99
|
1hiiA |
Comparative analysis of the x-ray structures of hiv-1 and hiv-2 proteases in complex with cgp 53820, a novel pseudosymmetric inhibitor |
|
15
|
99
|
1gnoA |
Hiv-1 protease (wild type) complexed with u89360e (inhibitor) |
|
14
|
99
|
1gnmA |
Hiv-1 protease mutant with val 82 replaced by asp (v82d) complexed with u89360e (inhibitor) |
|
17
|
99
|
1g35A |
Crystal structure of hiv-1 protease in complex with inhibitor, aha024 |
|
16
|
99
|
1g2kA |
Hiv-1 protease with cyclic sulfamide inhibitor, aha047 |
|
44
|
203
|
1g6lA |
1.9a crystal structure of tethered hiv-1 protease |
|
19
|
99
|
1fqxA |
Crystal structure of the complex of hiv-1 protease with a peptidomimetic inhibitor |
|
14
|
99
|
1gnnA |
Hiv-1 protease mutant with val 82 replaced by asn (v82n) complexed with u89360e (inhibitor) |
|
22
|
104
|
1fmbA |
Eiav protease complexed with the inhibitor hby-793 |
|
27
|
113
|
1fivA |
Structure of an inhibitor complex of proteinase from feline immunodeficiency virus |
|
18
|
99
|
1fejC |
Structural implications of drug resistant mutants of hiv-1 protease: high resolution crystal structures of the mutant protease/substrate analog complexes |
|
17
|
99
|
1fg6C |
Structural implications of drug resistant mutants of hiv-1 protease: high resolution crystal structures of the mutant protease/substrate analog complexes |
|
19
|
99
|
1fgcC |
Structural implications of drug resistant mutants of hiv-1 protease: high resolution crystal structures of the mutant protease/substrate analog complexes |
|
17
|
99
|
1ffiC |
Structural implications of drug resistant mutants of hiv-1 protease: high resolution crystal structures of the mutant protease/substrate analog complexes |
|
18
|
99
|
1fg8C |
Structural implications of drug resistant mutants of hiv-1 protease: high resolution crystal structures of the mutant protease/substrate analog complexes |
|
16
|
99
|
1f7aA |
How does a symmetric dimer recognize an asymmetric substrate? a substrate complex of hiv-1 protease. |
|
18
|
99
|
1ff0C |
Structural implications of drug resistant mutants of hiv-1 protease: high resolution crystal structures of the mutant protease/substrate analog complexes. |
|
18
|
99
|
1jldA |
Potent hiv protease inhibitors containing a novel (hydroxyethyl)amide isostere |
|
16
|
99
|
1fffC |
Structural implications of drug resistant mutants of hiv-1 protease : high resolution crystal structures of the mutant protease/substrate analog complexes. |
|
17
|
99
|
1fb7A |
Crystal structure of an in vivo hiv-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance |
|
15
|
99
|
1ebzA |
Hiv-1 protease in complex with the inhibitor bea388 |
|
15
|
99
|
1ebyA |
Hiv-1 protease in complex with the inhibitor bea369 |
|
17
|
99
|
1ec0A |
Hiv-1 protease in complex with the inhibitor bea403 |
|
15
|
99
|
1ec1A |
Hiv-1 protease in complex with the inhibitor bea409 |
|
15
|
99
|
1ec3A |
Hiv-1 protease in complex with the inhibitor msa367 |
|
19
|
99
|
1ebkC |
Structural and kinetic analysis of drug resistant mutants of hiv-1 protease |
|
15
|
99
|
1ec2A |
Hiv-1 protease in complex with the inhibitor bea428 |
|
17
|
99
|
1ebwA |
Hiv-1 protease in complex with the inhibitor bea322 |
|
18
|
99
|
1dw6C |
Structural and kinetic analysis of drug resistant mutants of hiv-1 protease |
|
16
|
99
|
1d4kA |
Hiv-1 protease complexed with a macrocyclic peptidomimetic inhibitor |
|
15
|
99
|
1difA |
Hiv-1 protease in complex with a difluoroketone containing inhibitor a79285 |
|
14
|
99
|
1d4sA |
Hiv-1 protease v82f/i84v double mutant/tipranavir complex |
|
17
|
99
|
1d4hA |
Hiv-1 protease in complex with the inhibitor bea435 |
|
19
|
99
|
1dazC |
Structural and kinetic analysis of drug resistant mutants of hiv-1 protease |
|
16
|
99
|
1dmpA |
Structure of hiv-1 protease complex |
|
15
|
99
|
1d4lA |
Hiv-1 protease complexed with a macrocyclic peptidomimetic inhibitor |
|
16
|
99
|
1d4yA |
Hiv-1 protease triple mutant/tipranavir complex |
|
18
|
99
|
1d4iA |
Hiv-1 protease in complex with the inhibitor bea425 |
|
17
|
99
|
1d4jA |
Hiv-1 protease in complex with the inhibitor msl370 |
|
15
|
99
|
1cpiA |
Regioselective structural and functional mimicry of peptides. design of hydrolytically stable cyclic peptidomimetic inhibitors of hiv-1 protease |
|
15
|
99
|
1c6yA |
Alternate binding site for the p1-p3 group of a class of potent hiv-1 protease inhibitors as a result of concerted structural change in 80's loop. |
|
18
|
99
|
1bwaA |
Hiv-1 protease (v82f/i84v) double mutant complexed with xv638 of dupont pharmaceuticals |
|
19
|
99
|
1iziA |
Inhibitor of hiv protease with unusual binding mode potently inhibiting multi-resistant protease mutants |
|
16
|
99
|
1bv7A |
Counteracting hiv-1 protease drug resistance: structural analysis of mutant proteases complexed with xv638 and sd146, cyclic urea amides with broad specificities |
|
15
|
99
|
1bwbA |
Hiv-1 protease (v82f/i84v) double mutant complexed with sd146 of dupont pharmaceuticals |
|
13
|
99
|
1ivqA |
The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors |
|
14
|
99
|
1c6zA |
Alternate binding site for the p1-p3 group of a class of potent hiv-1 protease inhibitors as a result of concerted structural change in 80's loop. |
|
11
|
99
|
1bvgA |
Hiv-1 protease-dmp323 complex in solution, nmr minimized average structure |
|
14
|
99
|
1c6xA |
Alternate binding site for the p1-p3 group of a class of potent hiv-1 protease inhibitors as a result of concerted structural change in 80's loop. |
|
16
|
99
|
1ivpA |
The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors |
